Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Share-based Compensation (2020 - 2025)

Beauty Health (SKIN) has disclosed Share-based Compensation for 6 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation fell 68.17% to $2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $17.1 million, a 26.03% decrease, with the full-year FY2024 number at $26.7 million, up 18.42% from a year prior.
  • Share-based Compensation was $2.5 million for Q3 2025 at Beauty Health, down from $5.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $8.5 million in Q2 2023 to a low of $34000.0 in Q1 2021.
  • A 5-year average of $5.3 million and a median of $5.8 million in 2024 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: skyrocketed 20632.35% in 2022, then crashed 70.36% in 2023.
  • Beauty Health's Share-based Compensation stood at $3.8 million in 2021, then skyrocketed by 100.82% to $7.6 million in 2022, then plummeted by 70.36% to $2.3 million in 2023, then surged by 159.08% to $5.8 million in 2024, then crashed by 58.03% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Share-based Compensation are $2.5 million (Q3 2025), $5.3 million (Q2 2025), and $3.5 million (Q1 2025).